S-707106
/ Shionogi
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 22, 2021
An open-label phase Ⅰ/Ⅱ a clinical trial of 11β-HSD1 inhibitor for Cushing's syndrome and autonomous cortisol secretion.
(PubMed, J Clin Endocrinol Metab)
- "S-707106 is an effective insulin sensitizer and anti-sarcopenic and anti-obesity medication for these patients."
Clinical • Journal • Diabetes • Endocrine Disorders • Genetic Disorders • Metabolic Disorders • Obesity • Sarcopenia
1 to 1
Of
1
Go to page
1